Antibody-drug conjugates (ADCs) are an important class of highly potent biopharmaceutical drugs designed as a targeted therapy for the treatment of people with cancer. It is the new generation anticancer drug. Unlike chemotherapy, ADCs are intended to target and kill only the cancer cells and spare healthy cells. ADCs are complex molecules composed of an antibody linked to a biologically active cytotoxic (anticancer) payload or drug.
GMP-certified production of payloads is possible if needed:
- Separate GMP-facility equipped with BioSafety Cabinet and HEPA filters ( ca 20 m2 room, including human lock and working area)
- Experience in GMP-certified production of anticancer compounds
- Experience in work with highly toxic materials
- Max batch ca 100 g
Please see our detailed presentation of ADC payloads (.pdf 1,7 MB)